2 results
Approved WMOCompleted
Does oral simvastatin at standard doses alter BMP pathway signalling in colorectal cancer specimens in humans?
Approved WMOPending
Primary Objective• To characterize preliminary targeting properties of [68Ga]-NeoBOMB1 in patients with malignancies known to overexpress GRPR.Secondary objectives• To assess safety and tolerability of a single diagnostic dose of [68Ga]-NeoBOMB1…